TEVA

Stocks Skittish on Tax Worries

By Anthony Mirhaydari, InvestorPlace Market Strategist
Stocks fell on amid doubts over the fate of the GOP's tax cut plans. The doubt hit investors after a number of Republican senators expressed reservations about the amount of the child tax credit.

Teva Pharmaceutical Stock Surges on Layoffs, Dividend Suspension

By William White, InvestorPlace Writer
Teva Pharmaceutical (TEVA) stock was surging on Thursday following the announcement of its restructuring plans for the next two years.

Monday’s Vital Data: Facebook Inc (FB), Monsanto Company (MON) and Teva Pharmaceutical Industries Limited (TEVA)

By Joseph Hargett, InvestorPlace Contributor
Facebook (FB) calls rise on bullish research note, Monsanto (MON) puts options pile on EU warning and Teva (TEVA) surges on jobs cuts.

Teva Pharmaceutical Stock Surges on Job Cuts Talk

By William White, InvestorPlace Writer
Teva Pharmaceutical (TEVA) stock was on its way up today on talk that the company is looking to reduce its cost by cutting jobs.

Why Teva Pharmaceutical Stock is Surging Today

By William White, InvestorPlace Writer
Teva Pharmaceutical (TEVA) stock was on the rise Monday following new of some major changes in leadership at the company.

10 Blue-Chip Stocks That Could Wreck Your Retirement

By Louis Navellier, Editor, Growth Investor
Knowing what not to buy is just as important as knowing what to buy. These blue-chip stocks are showing warning signs.

Tuesday’s Vital Data: Alibaba Group Holding Ltd (BABA), Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Valeant Pharmaceuticals Intl Inc (VRX)

By Joseph Hargett, InvestorPlace Contributor
Alibaba (BABA) options jump on target hike, Teva (TEVA) put options pile despite billionaire stake interest and Valeant (VRX) divests Sprout.

Teva Pharmaceutical (TEVA) Stock Sinks on Lowered Outlook

By William White, InvestorPlace Writer
Teva Pharmaceutical (TEVA) stock was down today after the company lowered its outlook for 2017 due to increasing competition.

4 High-Yield, High-Risk Dividend Stocks That Aren’t Worth It

By John Kilhefner, Senior Managing Editor, Lango Franchise
A high-yield dividend can be an attractive aspect to a stock, but that number alone doesn't make a stock worth buying.

Thursday’s Vital Data: Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Netflix, Inc. (NFLX) and JPMorgan Chase & Co. (JPM)

By Joseph Hargett, InvestorPlace Contributor
Teva (TEVA) options surge on Mylan N.V.’s generic drug approval, Netflix (NFLX) lifted at UBS and JPMorgan Chase (JPM) trades ex-dividend.

Mylan N.V. (MYL) Stock Gets Massive Boost From Generic MS Drug Approval

By William White, InvestorPlace Writer
Mylan (MYL) stock was flying high today on approval from the FDA for a generic version of Teva's (TEVA) MS drug Copaxone.

Is Teva Pharmaceutical (TEVA) Stock Worth the Risk?

By Luke Lango, InvestorPlace Senior Investment Analyst
TEVA stock has tanked over the past several months, but is this stock finally cheap enough to compensate for the leveraged risk profile?

A New CEO Only Emboldens the Case for Teva Pharmaceutical Industries Ltd (TEVA) Stock

By Louis Navellier, Editor, Growth Investor
Teva Pharmaceuticals has a new CEO, and despite TEVA stock being down more than 53% this year, now may be a time to buy.

Go Long Teva Pharmaceuticals Industries Ltd (ADR) (TEVA) Stock With Less Speculation

By Chris Tyler, InvestorPlace Contributor
Conditions are looking up for TEVA stock both off and on the price chart, but position more smartly with this play.

Tuesday’s Vital Data: Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Snap Inc (SNAP) and Tesla Inc (TSLA)

By Joseph Hargett, InvestorPlace Contributor
Teva (TEVA) call options surge on new CEO, Snap (SNAP) panned at Deutsche Bank and Tesla (TSLA) announces layoffs at SolarCity.

Post-Hurricane Enthusiasm Keeps Pushing S&P 500 Higher

By Anthony Mirhaydari, InvestorPlace Market Strategist
But can the S&P 500 keep riding higher, or are the markets due for a bounce in the near term?

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Soars on New CEO News

By William White, InvestorPlace Writer
Teva Pharmaceutical (TEVA) stock was flying high today following news of a new CEO that will be joining the company soon.

Teva Pharmaceutical Industries Ltd ADR (TEVA) Names Kare Schultz As CEO

By Robert Lakin, InvestorPlace Contributor
Teva ended its leadership uncertainty with the selection of long-time pharma exec Kåre Schultz as CEO, TEVA stock is up this morning.

Battered Teva Pharmaceutical Industries Ltd (ADR) Stock Still Is Toxic

By Bret Kenwell, InvestorPlace Contributor
Teva Pharmaceutical is waist-deep in debt and just slashed its dividend. TEVA stock might be oversold and undervalued, but it's also still a mess.
Load More